Literature DB >> 27900089

Pregnancy and cesarean delivery after multimodal therapy for vulvar carcinoma: A case report.

Kuniaki Toriyabe1, Haruki Taniguchi2, Tokihiro Senda3, Masako Nakano2, Yoshinari Kobayashi2, Miho Izawa2, Hirohiko Tanaka2, Tetsuo Asakura2, Tsutomu Tabata4, Tomoaki Ikeda4.   

Abstract

Reports of pregnancy following treatment for vulvar carcinoma are extremely uncommon, as the main problem of subsequent pregnancy is vulvar scarring following radical surgery. We herein report the case of a patient who was diagnosed with stage I squamous cell carcinoma of the vulva at the age of 17 years and was treated with multimodal therapy, including neoadjuvant chemotherapy, wide local excision with bilateral inguinal lymph node dissection and adjuvant radiotherapy. The patient became pregnant spontaneously 9 years after her initial diagnosis and the antenatal course was good, except for mild acute pyelonephritis at 25 weeks of gestation. An elective caesarean section was performed at 38 weeks of gestation due to vulvar scarring following multimodal therapy, particularly radiotherapy. The patient remains alive and well, without signs of recurrence or metastasis 12 years after her diagnosis and treatment. Radical vulvectomy as well as multimodal therapy for vulvar carcinoma, particularly radiotherapy, may cause extensive skin scarring. The presence of vulvar scarring following multimodal therapy for vulvar carcinoma may increase the incidence of caesarean delivery.

Entities:  

Keywords:  caesarean delivery; multimodal therapy; pregnancy; squamous cell carcinoma; vulvar carcinoma

Year:  2016        PMID: 27900089      PMCID: PMC5103870          DOI: 10.3892/mco.2016.1021

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  9 in total

1.  Carcinoma of the vulva and subsequent succesful pregnancy.

Authors:  T DAHLE
Journal:  Acta Obstet Gynecol Scand       Date:  1959       Impact factor: 3.636

2.  Pregnancy and delivery following extensive vulvectomy.

Authors:  J H COLLINS; H W BIRCH; M PAILET; J K AVENT
Journal:  Am J Obstet Gynecol       Date:  1960-07       Impact factor: 8.661

3.  Pregnancy following radical vulvectomy for carcinoma of the vulva.

Authors:  A A GEMMELL; M HAINES
Journal:  J Obstet Gynaecol Br Emp       Date:  1960-04

4.  Pregnancy and vaginal delivery following radical surgery for cancer of the vulva; review of the literature and case report.

Authors:  A RUBIN; G C LEWIS
Journal:  Am J Obstet Gynecol       Date:  1953-06       Impact factor: 8.661

Review 5.  Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature.

Authors:  Koji Matsuo; Stephanie A Whitman; Erin A Blake; Charlotte L Conturie; Marcia A Ciccone; Carrie E Jung; Tsuyoshi Takiuchi; Masato Nishimura
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-04-19       Impact factor: 2.435

Review 6.  Pregnancy following radical vulvectomy for carcinoma of the vulva: a case report and literature review.

Authors:  J E Arjona; E Velasco; P Cervelo; E Espejo; I Pizarro; S Carrasco; C Castelo-Branco
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-05-26       Impact factor: 2.435

7.  New aspects of vulvar cancer: changes in localization and age of onset.

Authors:  Monika Hampl; Stella Deckers-Figiel; Juergen A Hampl; Daniel Rein; Hans G Bender
Journal:  Gynecol Oncol       Date:  2008-04-14       Impact factor: 5.482

8.  Pregnancy following vulvar squamous cell carcinoma: a report of two cases.

Authors:  Julia E Palmer; John A Tidy
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

9.  Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

Authors:  Sven Mahner; Julia Jueckstock; Felix Hilpert; Petra Neuser; Philipp Harter; Nikolaus de Gregorio; Annette Hasenburg; Jalid Sehouli; Annika Habermann; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Falk Thiel; Alexander Mustea; Werner Meier; Andreas du Bois; Lis-Femke Griebel; Linn Woelber
Journal:  J Natl Cancer Inst       Date:  2015-01-24       Impact factor: 13.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.